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Abstract
Wearable devices to detect changes in health
status are increasingly adopted by consumers, yet
hospitals remain slow to assimilate these devices into
clinical practice. Despite the clear benefits of
capturing clinical information in acutely ill patients,
such technology remains difficult to implement in
emergency medicine. To improve adoption, barriers
must first be removed. In our technical feasibility and
acceptability trial, we studied the deployment of a
wearable
wireless
biosensor
that
collects
physiological data. We enrolled 44 adult patients
receiving care in an emergency department
observation unit. After we consented patients for
participation, we applied biosensors to their chest and
collected basic demographic and clinical information.
We then collected biosensor data on an isolated
system and measured patient experience via an exit
survey. Throughout this process we documented and
studied technical challenges. Overall, the technology
was feasible to deploy in the emergency department
observation unit and was acceptable to participants.
Such technologies have tremendous future operational
and clinical implications in settings ranging from
emergency to home-care.

1. Introduction
Increased use of heart rate monitors, smartphone
health apps and cutaneous wearable monitors provide
unobtrusive, important insights into health
conditions.1 Paired devices and companion
smartphone apps can detect rhythm changes in
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individuals with atrial fibrillation, measure adherence
to oral medications and track changes in spirometry in
individuals with lung disease.2-5 Despite successful
demonstration projects that indicate the feasibility of
using wearable devices to measure vital sign
parameters, there has been minimal adoption of
wearable devices for clinical use in the emergency
department.6
Emergency departments face rising volumes and
increasingly ill patients. In acute settings,
understanding the context prior to the presentation of
a critically ill patient can help make a diagnosis while
providing important information that may guide
medical management.6,7 Unobtrusive wearable
devices have the potential to change not only the
management of patients in the emergency department,
but also practices in patient throughput and decisions
to admit or discharge patients through more frequent
monitoring and under ambulatory conditions.8
While some investigations suggest that capturing
these real-time biophysiologic changes may alter
certain health decisions (e.g., detection of arrhythmia
may alter the decision to initiate anticoagulation
pharmacotherapy), few hospitals have consistently
integrated wearable devices into their inpatient
practice.9 The delay in introduction of wearable
devices in the hospital setting is likely due to
significant information security and wireless data
transmission capability challenges that limit
integration with hospital data solution systems.
Wireless biosensors that capture important vital
sign information may improve detection of adverse
events in the outpatient setting and may serve as a
vehicle to conduct traditional inpatient care at home in
the setting of a “home hospital” system.10 There is
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additional benefit of translating the experience of
wearable biosensors from the outpatient setting into
the hospital, especially the emergency department.
Wearable biosensors can improve a hospital’s capacity
to conduct telemetry in non-traditional settings,
provide safer quality care, and improve the patient
hospital experience. Despite the benefits of developing
and using wearable biosensors in the hospital, there are
significant barriers that must be overcome prior to
successful deployment of these devices. In this
manuscript, we discuss our experience with
information technology challenges, biosensor design
considerations and human factors issues that affect the
successful deployment of a wearable biosensor
system.

2. Materials and Methods

rate in emergency department patients.8 Iterative
refinements of the original version of the wearable
biosensor had been integrated into the novel version
used in this investigation.

Figure 1: A cutaneous, wearable biosensor, the Philips
BX100.

We conducted a technical feasibility trial that
deployed a prototype wireless wearable biosensor in
the emergency department observation unit (EDOU)
of an urban, academic, quaternary care center. Our
emergency department has an annual volume of
63,000 patients per year, 5-10% of which receive care
in an integrated EDOU annually. The EDOU is
designed to function like a short-stay hospital unit and
manages patients who have projected hospital stays of
up to 48 hours. The intention of the unit is to provide
additional time beyond a typical emergency
department visit for additional diagnostic and
therapeutic interventions for patients who may
otherwise not require an inpatient admission in our
hospital. Our investigation was approved by the
Partners Healthcare Institutional Review Board. We
enrolled adult emergency department patients who
were assigned by the primary clinical team to the
EDOU.

The wireless wearable biosensors are connected to
a Wi-Fi network in the EDOU via two BLE routers
and a wireless access point installed in the ceiling of
the EDOU. We elected to utilize a separate BLE
network with wireless access point to prevent the
wearable sensors from communicating with our
hospital network. This step ensured that critical
clinical patient data could not be interdicted by
malicious software using the biosensor as a bridge.
Proprietary software (access controller software and
business logic software) installed on the physical
servers at the EDOU nurses’ station provides
management of connected biosensors and facilitates
communication with the clinical research database. A
clinical research mobile application installed on a
tablet computer provides a clinician interface for
patient assignment and review of biosensor data.

2.1. Wearable Biosensor and Connectivity

English speaking patients, ages 18 and older,
receiving care in the EDOU were eligible for this
study. We enrolled patients between April and June of
2019. We identified potential participants through
passive screening of the electronic medical record
(EMR). The research team approached potentially
eligible participants and confirmed eligibility criteria.
We obtained written informed consent from interested
participants.

We deployed a single-use, cutaneous, chest-worn
investigational biosensor that collects physiological
data and contextual parameters consisting of heart
rate, respiratory rate, activity level, activity type, and
posture (Philips Connecting Sensing, Cambridge,
MA) (Figure 1).8 The biosensor is made of disposable
foam with a hydrocolloid adhesive that houses a
lithium coin battery, Bluetooth Low Energy (BLE)
radio, accelerometer, and two hydrogel-based
electrocardiogram (ECG) electrodes. An advanced
hydrocolloid adhesive allows the biosensor to adhere
to human skin and is designed to minimize irritation
while maximizing adhesion. A previous version of this
biosensor had been demonstrated to record respiratory

2.2. Eligibility and Consent

2.3. Study Procedures
Consented patients underwent a skin assessment
and skin preparation procedure (similar to routine
ECG lead preparation) prior to biosensor placement.
We collected a brief medical history and demographic
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information prior to biosensor placement and patients
received a wristband to indicate study participation.
Enrollment began at the time of biosensor placement.
We placed biosensors on the upper left chest and
patients wore the device for the full duration of their
EDOU stay. If a patient's stay in the EDOU exceeded
24 hours, study staff performed daily device adhesion
and skin assessments. During study participation,
patients were free to move in and out of the EDOU
without limitation. Before patient discharge from the
EDOU, study staff removed the biosensor and
performed a post-removal skin assessment.
Participants were asked to complete the Participant
Experience Questionnaire, a seven-question survey
aimed to rate the overall experience and level of
comfort of wearing the biosensor. Participants who
successfully completed all protocol-required activities
were compensated with a $50 gift card.
Enrollment

Informed
Consent

Monitoring*

Device
Adhesion
Assessment

Study
Completion**

Device
Adhesion
Assessment

Eligibility
Screening

Skin
Assessment

Skin
Assessment

Medical
History and
Demographics

Skin
Assessment

applied for less than 12 hours, participant requested
withdrawal from the study, and enrolled participant
but no biosensor applied given an alternative triage
decision outside of EDOU.

G10 Biosensor
Placement

*Repeat 1x every
24 hours
throughout
participation

G10 Biosensor
Removal

Participant
Experience
Questionnaire

**Before
discharge from
EDOBs or at 5
days (whichever
is sooner)

Figure 2: Study schema

2.4 Data Collection and Analysis

Figure 3: Enrollment of study participants

The research team collected and recorded clinical
data team on paper case report forms (CRFs) and then
transcribed into the Datatrak Electronic Data Capture
(EDC) system.11 Datatrak is a secure, web-based EDC
system that allows for capture and delivery of data
with advanced reporting and optimized workflow.
We collected basic demographic information on all
study participants and calculated basic descriptive
statistics.
We collected biosensor data in a separate research
database to enable analysis related to the technology
deployment, system, and biosensor performance.

The majority of enrolled patients were white
females (56.8%) (Table 1). Eighty-two percent (n=36)
of patients enrolled in the study were discharged to
home from the EDOU, and the average length of stay
in the EDOU was 23.7 hours.

3. Results
During the study period, 290 patients were
screened, and 52 individuals met eligibility criteria
and were approached by a member of the research
team regarding participation. Of those, 86.5% (n=45)
consented to participate in the study. Of the 45 patients
consented to the study, 44 patients were enrolled and
40 patients completed all protocol-required study
activities. Four participants were unable to complete
the study due to incomplete data (e.g., biosensor

Gender
Male, n (%)
Female
Race
White
Black or African American
Asian
Other
Ethnicity
Hispanic or Latino
Non-Hispanic or Latino
Average Age (Years)
Mean (±SD)
Median
Min, Max
BMI (kg/m2)
Mean (±SD)
Median

19 (43.2%)
25 (56.8%)
31 (70.5%)
6 (13.6%)
2 (4.5%)
5 (11.4%)
7 (15.9%)
37 (84.1%)
54.0 (20.1)
53.5
(21, 84)
30.3 (8.7)
27.4
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Min, Max
Table 1. Participant characteristics

(20.2, 61.6)

We were able to successfully place the wireless
wearable biosensors on study participants, connect the
sensor to the network, and collect 12 hours of
biosensor data 93.2% (n=41) times. In 5.9% (n=3)
instances, we were not able to successfully connect the
sensor to the installed network and the initial biosensor
was replaced with a new device. For seven of our
enrollments, we also noted that we were unable to
connect the tablet to the installed network. We noted
that the data server placed under a work desk had been
unplugged. We power reset and rebooted the system,
which then acquired a signal from established
biosensors. When the network was inactive, the
established biosensors stored data locally to upload to
the server when connectivity was restored. Across all
biosensors used in the study, 0.1% (SD=0.2) of
calculated observations were not uploaded to the
server due to network latency.

3.2 Participant Experience Questionnaire
After biosensor removal and skin assessment,
participants completed the Participant Experience
Questionnaire. This questionnaire is comprised of six
questions that asked participants to rate their overall
experience and comfort level wearing the biosensor
during their stay in the EDOU. Overall, 93.2% of
patients reported that they experienced no discomfort
during the time that they were wearing the device;
90.9% of patients said they would wear the device
again. Results of the Participant Experience
Questionnaire are shown in Table 2.
Experienced discomfort
during placement of device
Experienced discomfort
while wearing device

Experienced discomfort
during device removal

Inconvenienced while
wearing device

None: 100% (n=44)
None: 93.2% (n=41)
Minimal: 2.3% (n=1)
Missing data: 4.5%
(n=2)
None: 59.1% (n=26)
Minimal: 27.3%
(n=12)
Mild: 2.3% (n=1)
Moderate: 4.5% (n=2)
Severe: 2.3% (n=1)
Missing data: 4.5%
(n=2)
None: 93.2% (n=41)
Mild: 2.3% (n=1)
Missing data: 4.5%
(n=2)

Power button clicking was
noticeable

No: 95.5% (n=42)
Missing data: 4.5%
(n=2)
Would wear the device
Yes: 90.9% (n=40)
again
No: 4.5% (n=2)
Missing data: 4.5%
(n=2)
Table 2: Patient Experience Questionnaire

4. Discussion
This investigation demonstrates that a wireless
wearable biosensor that collects physiological data
and contextual parameters is feasible to deploy in an
EDOU. We additionally demonstrated that patients are
accepting of biosensors and are willing to wear them
in this setting. One of our most important findings was
the high degree of multidisciplinary collaboration
needed to deploy a wireless biosensor system in the
emergency department. These results suggest that the
deployment of a wireless wearable biosensor system
in this setting is feasible. Our deployment roadmap
may be used by others seeking to use similar
technology in hospital settings.
Participants in the study were accepting of the use
of cutaneous wireless wearable biosensors during their
emergency department stay. They considered the
device unobtrusive and comfortable. Participants did
not feel inconvenienced by wearing the device, and
most would be willing to wear a biosensor during their
emergency department stay. Additionally, we were
able to train research assistants to apply and connect
the biosensor to the wireless network. In the future,
patients who enter the emergency department may be
able to have the biosensor placed by nursing staff or a
medical assistant during their initial triage, either in
the waiting room or inside the emergency department.
In aggregate, this data suggests that the sensor is easy
to operate, and patients who may need supplementary
monitoring in the emergency department will wear
these devices or similar devices.
The success of this investigation relied on close
collaboration with staff from information security,
hospital
engineering,
emergency
department
operations as well as research staff. We recommend
early engagement with hospital information security
personnel. Initial deployment considerations such as
where to place devices on a hospital network can take
time to elucidate. There are advantages in integrating
biosensors into existing networks—they allow for
easy integration into hospital workflows and allow
nascent investigations to understand potential
deficiencies in signal transmission. At the same time,
integration into a secure hospital network may be
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time-consuming and beyond the scope of an initial
feasibility demonstration project. In response, we
recommend consideration of alternative data
collection and integration measures. These may
include installing a separate, independent network in a
small portion of the study site or enabling passive data
collection from biosensors using low energy Bluetooth
or active radiofrequency identification systems. These
systems may represent a novel workflow where the
isolation of biosensor data allows for a wireless
biosensor system to continue to function in the event
of network downtime.
In this investigation, we decided, in collaboration
with our hospital information security specialists, to
install an independent wireless network to
accommodate the biosensor. This approach required
us to interface with our hospital’s engineering group
in order to install a simple network consisting of two
routers and a series of data servers. Like most hospital
emergency departments, we are constrained by space,
and the integration of these devices among the ebb and
flow of patient volume, nursing and provider
workflows was critical. We ultimately feel our
solution was advantageous since it allowed us to
isolate biosensor data from other clinical data in the
emergency department and enabled us to assess for
potential disruptions in data transmission from
biosensor to network.

4.1. Implications of this work
There are several important implications to this
work. First, the deployment of wearable biosensors
may alter the method in which emergency
department’s triage and deliver care to patients that
traditionally needed a wired monitor. For example,
patients with high-risk chief complaints like chest
pain, palpitations, or shortness of breath typically
require a room in the emergency department or
hallway bed with a wired monitor to measure dynamic
changes in heart rate, oxygen saturation, or respiratory
rate. The potential to expand the footprint within the
emergency department in which these patients can be
monitored and cared for may allow emergency
departments to think about where these patients are
roomed (e.g., they could potentially be cared for in
spaces that traditionally did not have wired monitors).
Second, independent wireless networks can be
installed to cover the emergency department and
waiting room. This setup permits wireless,
unobtrusive physiological data transmission to be
initiated at initial triage of emergency department
patients. Current emergency medicine triage practices
rely on emergency department staff obtaining vital
signs as patients register in the waiting room.

Depending on the emergency severity index (ESI)
assigned to the patient, the presence of beds in the
emergency department and availability of providers,
patients may wait for extended periods in the waiting
room. The wireless wearable biosensors could be
deployed among waiting room patients to detect
potential changes in physiology that may necessitate
an “up triage” or potential change in ESI and
subsequent rapid entry into the emergency department.
Finally, now that we have established the
feasibility of deploying wireless biosensors in the
emergency department, our next steps are to
understand the impact on clinical operations and care
that a wireless biosensor may have in emergency
medicine. Although data can be collected on patients
in the emergency department, an infrastructure to
respond and manage the additional numbers of
potential care areas that are enabled through a wireless
and unobtrusive biosensor needs to be developed and
studied.
4.2. Limitations and future work.
This investigation had several limitations. First, we
deployed the wearable biosensor in a single, urban,
academic emergency department. Our experience with
designing and implementing this study may vary in
community emergency departments or other hospital
locations. Because we wanted to demonstrate that the
use of the biosensor system was feasible, we did not
study methods in which biosensor data should be
integrated into clinical workflow. We also did not test
the accuracy of data collected from the biosensor.
Finally, we did not consider the cost of installing the
infrastructure necessary to utilize the sensor. We
installed two routers and a small, off-the-shelf data
server to support the flow of biosensor data in the
study. Future investigations should include an
economic analysis on the financial feasibility of such
a system.
In the future, we anticipate investigating
operational factors that allow for the integration of
wearable biosensor data into emergency department
workflows. This is of particular interest to us as
emergency department patients may move through
various departments in order to obtain imaging studies
and other procedures during their emergency
department stay. It will be important to understand
how biosensors are applied and how consultants are
notified of the presence of the sensor. We also plan to
understand how the biosensor can be used during the
transition from emergency department to inpatient,
observation, or outpatient care.

5. Conclusion
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Overall, this study demonstrated that a wireless
wearable biosensor system is a feasible technology to
deploy in the emergency department. Participants who
wore the biosensor were accepting of the biosensors
and reported that it was comfortable; we experienced
no serious adverse reactions to the biosensor. We were
able to successfully place biosensors and acquire
signal 93.2% of the time. This investigation lays the
foundation for future studies that will understand how
the biosensor integrates into clinical workflows.
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